Posts by: Iqra Mumal, MSc

Iqra Mumal, MSc

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

March 23, 2020March 23, 2020

AAV Patients at 7 Times Higher Risk for Infections, Study Finds

News

People with ANCA-associated vasculitis have about seven times the risk of developing an infection compared with individuals in the general population, a study found. The study, “Characterizing infection in ... Read more

March 11, 2020March 11, 2020

AAV Does Not Raise Healthcare Use, Mortality in Goodpasture’s Syndrome, Study Says

News

ANCA-associated vasculitis does not increase healthcare resource utilization or in-hospital mortality rates in patients with Goodpasture’s syndrome, a study reports. The study, “Impact of ANCA-Associated Vasculitis on Outcomes of ... Read more

September 30, 2019September 30, 2019

Low-dose Glucocorticoid Regimen May Effectively Treat AAV in Elderly Patients, Study Suggests

News

A low-dose glucocorticoid regimen, in which intravenous methylprednisolone (a type of steroid) is not routinely used, can be used to effectively treat ANCA-associated vasculitis in elderly patients, a new study ... Read more

September 26, 2019October 24, 2019

AAV Patients Treated with Immunosuppressive Therapy More Likely to Develop Infectious Complications

News

Patients with ANCA-associated vasculitis (AAV) treated with immunosuppressive agents have a higher risk of developing infectious complications, including pneumonia, sepsis, and fungal infection, a new study shows. The study, ... Read more

September 17, 2019

Lung Ultrasound Accurately Detects Lesions in AAV, Study Shows

News

Lesions in the lungs caused by ANCA-associated vasculitis (AAV) are variable among patients, but lung ultrasound appears to be as good as computed tomography (CT) scans at detecting them, ... Read more

July 1, 2019July 1, 2019

Complement System Plays Role in ANCA-associated Vasculitis, Regardless of ANCA Subtype, Study Says

News

The complement system, an important part of immunity, is activated in ANCA-associated vasculitis patients with myeloperoxidase (MPO) antibodies as well as those with proteinase 3 (PR3) ANCA antibodies, but ... Read more

June 24, 2019

Study: Rituxan Reduces Disease Activity in EGPA, But Relapses Stay High

News

Treatment with Rituxan (rituximab) had some efficacy in eosinophilic granulomatosis with polyangiitis patients, leading to a reduction in glucocorticoid requirement, but asthma and ear, nose and throat (ENT) relapse ... Read more

June 4, 2019

Plasma Exchange Effective for AAV Patients with Severe Renal Damage, Study Reports

News

Treatment using plasma exchange can help ANCA-associated vasculitis patients with severe renal damage become independent of dialysis in just a few weeks, according to a study. The study, “Plasma ... Read more

May 28, 2019May 28, 2019

Blood in Urine Linked to Higher Risk of Kidney Disease Relapse in AAV Patients, Study Finds

News

The presence of blood in the urine is associated with a four times higher risk of kidney disease relapse within 44 months after achieving remission in patients with ANCA-associated ... Read more

May 23, 2019

Urinary Gremlin Protein Levels a Potential Biomarker for ANCA-associated Renal Vasculitis, Study Finds

News

Levels of Gremlin — a protein that is overexpressed during kidney damage — in the urine may serve as a specific biomarker for ANCA-associated renal vasculitis, a study shows. ... Read more